Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MATRISIAN, Lynn M")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 69

  • Page / 3
Export

Selection :

  • and

Matrix metalloproteases in head and neck cancerROSENTHAL, Eben L; MATRISIAN, Lynn M.Head & neck. 2006, Vol 28, Num 7, pp 639-648, issn 1043-3074, 10 p.Article

Protease inhibitors in oral carcinogenesis and chemopreventionLIPPMAN, Scott M; MATRISIAN, Lynn M.Clinical cancer research. 2000, Vol 6, Num 12, pp 4599-4603, issn 1078-0432Article

Loss of functional fas ligand enhances intestinal tumorigenesis in the min mouse modelFINGLETON, Barbara; CARTER, Kathy J; MATRISIAN, Lynn M et al.Cancer research (Baltimore). 2007, Vol 67, Num 10, pp 4800-4806, issn 0008-5472, 7 p.Article

Matrix metalloproteinases and cellular motility in development and diseaseVANSAUN, Michael N; MATRISIAN, Lynn M.Birth defects research. Part C. Embryo today : reviews. 2006, Vol 78, Num 1, pp 69-79, 11 p.Article

Matrix metalloproteinases in tumor-host cell communicationLYNCH, Conor C; MATRISIAN, Lynn M.Differentiation (London). 2002, Vol 70, Num 9-10, pp 561-573, issn 0301-4681, 13 p.Article

[Proteases and protease inhibitors in cancer]MATRISIAN, Lynn M; DANØ, Keld; BRüNNER, Nils et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 1999, Vol 107, Num 1, issn 0903-4641, 180 p.Serial Issue

Matrix metalloproteinase inhibitors and cancer: Trials and tribulationsCOUSSENS, Lisa M; FINGLETON, Barbara; MATRISIAN, Lynn M et al.Science (Washington, D.C.). 2002, Vol 295, Num 5564, pp 2387-2392, issn 0036-8075Article

The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouseHULBOY, Diana L; GAUTAM, Shiva; FINGLETON, Barbara et al.Oncology reports. 2004, Vol 12, Num 1, pp 13-17, issn 1021-335X, 5 p.Article

Membrane-type matrix metalloproteinasesSEIKI, M.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 1999, Vol 107, Num 1, pp 137-143, issn 0903-4641Article

Programmed cell death and the caspasesSALVESEN, G. S.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 1999, Vol 107, Num 1, pp 73-79, issn 0903-4641Article

Clinical studies with matrix metalloproteinase inhibitorsBROWN, P. D.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 1999, Vol 107, Num 1, pp 174-180, issn 0903-4641Article

Stabilized β-catenin immortalizes colonic epithelial cellsWAGENAAR, Rebecca A; CRAWFORD, Howard C; MATRISIAN, Lynn M et al.Cancer research (Baltimore). 2001, Vol 61, Num 5, pp 2097-2104, issn 0008-5472Article

The urokinase receptor. A cell surface, regulated chemokineBLASI, F.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 1999, Vol 107, Num 1, pp 96-101, issn 0903-4641Article

The Translational Research Working Group Developmental Pathway for Interventive Devices : Navigating early translational cancer researchDORFMAN, Gary S; LAWRENCE, Theodore S; MATRISIAN, Lynn M et al.Clinical cancer research (Print). 2008, Vol 14, Num 18, pp 5700-5706, issn 1078-0432, 7 p.Article

Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironmentACUFF, Heath B; CARTER, Kathy J; FINGLETON, Barbara et al.Cancer research (Baltimore). 2006, Vol 66, Num 1, pp 259-266, issn 0008-5472, 8 p.Article

Clinical relevance of the urokinase plasminogen activator system in breast cancerLOOK, M. P; FOEKENS, J. A.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 1999, Vol 107, Num 1, pp 150-159, issn 0903-4641Article

TheTranslational Research Working Group Developmental Pathway for Image-Based Assessment Modalities : Navigating early translational cancer researchDORFMAN, Gary S; SULLIVAN, Daniel C; SCHNALL, Mitchell D et al.Clinical cancer research (Print). 2008, Vol 14, Num 18, pp 5678-5684, issn 1078-0432, 7 p.Article

Imaging matrix metalloproteinases in cancerSCHERER, Randy L; MCINTYRE, J. Oliver; MATRISIAN, Lynn M et al.Cancer metastasis reviews. 2008, Vol 27, Num 4, pp 679-690, issn 0167-7659, 12 p.Article

A protective role for matrix metalloproteinase-3 in squamous cell carcinomaMCCAWLEY, Lisa J; CRAWFORD, Howard C; KING, Lloyd E et al.Cancer research (Baltimore). 2004, Vol 64, Num 19, pp 6965-6972, issn 0008-5472, 8 p.Article

Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivoVARGO-GOGOLA, Tracy; FINGLETON, Barbara; CRAWFORD, Howard C et al.Cancer research (Baltimore). 2002, Vol 62, Num 19, pp 5559-5563, issn 0008-5472, 5 p.Article

An odyssey from breast to bone : Multi-step control of mammary metastases and osteolysis by matrix metalloproteinasesLOCHTER, A; BISSELL, M. J.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 1999, Vol 107, Num 1, pp 128-136, issn 0903-4641Article

The other side of MMPs : Protective roles in tumor progressionMARTIN, Michelle D; MATRISIAN, Lynn M.Cancer metastasis reviews. 2007, Vol 26, Num 3-4, pp 717-724, issn 0167-7659, 8 p.Article

Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factorsLYNCH, Conor C; CRAWFORD, Howard C; MATRISIAN, Lynn M et al.International journal of oncology. 2004, Vol 24, Num 6, pp 1565-1572, issn 1019-6439, 8 p.Article

Matrix metalloproteinases in colorectal cancer: Is it worth talking about?WAGENAAR-MILLER, Rebecca A; GORDEN, Lee; MATRISIAN, Lynn M et al.Cancer metastasis reviews. 2004, Vol 23, Num 1-2, pp 119-135, issn 0167-7659, 17 p.Article

Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferationHENRIET, P; BLAVIER, L; DECLERCK, Y. A et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 1999, Vol 107, Num 1, pp 111-119, issn 0903-4641Article

  • Page / 3